Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …

Cardiovascular disease (CVD) due to atherosclerosis of the arterial vessel wall and to
thrombosis is the foremost cause of premature mortality and of disability-adjusted life years …

Background Short-term studies have shown that bempedoic acid, an inhibitor of ATP citrate
lyase, reduces levels of low-density lipoprotein (LDL) cholesterol. Data are limited regarding …

2016 Chinese guidelines for the management of dyslipidemia in adults Page 1 Journal of
Geriatric Cardiology (2018) 15: 1-29 ©2018 JGC All rights reserved; www.jgc301.com http://www.jgc301.com; …

Context An estimated 10% to 20% of patients cannot tolerate statins or adequate doses to
achieve treatment goals. Plasma proprotein convertase subtilisin/kexin type 9 (PCSK9) …

Statin therapy is generally well tolerated and very effective in the prevention and treatment of
cardiovascular disease, regardless of cholesterol levels; however, it can be associated with …

Книга посвящена актуальнейшей медико-социальной проблеме современности
острым и хроническим прогрессирующим нарушениям мозгового кровообращения …

Inflammation is an obligatory marker of arterial disease, both stemming from the
inflammatory activity of cholesterol itself and from well-established molecular mechanisms …

There are currently eight different classes of drugs available for lowering cholesterol levels.
There are currently seven HMG-CoA reductase inhibitors (statins) approved for lowering …

Rosuvastatin is a new generation HMG-CoA reductase inhibitor which exhibits some unique
pharmacologic and pharmacokinetic properties. It has low extrahepatic tissue penetration …